Applied DNA Sciences, Inc. (APDN) |
0.41 -0.018 (-4.21%) 03-28 16:00 |
Open: | 0.428 |
High: | 0.449 |
Low: | 0.41 |
Volume: | 50,371 |
Market Cap: | 7(M) |
PE Ratio: | -0.75 |
Exchange: | NASDAQ Capital Market |
Industry: | Diagnostics & Research |
Sector: | Healthcare |
Technical analysis | ||||
sell | buy |
Resistance 2: | 0.72 |
Resistance 1: | 0.59 |
Pivot price: | 0.46 |
Support 1: | 0.37 |
Support 2: | 0.31 |
52w High: | 1.86 |
52w Low: | 0.37 |
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide real-time authentication of molecular tags in the field; and CertainT, which indicates the use of tagging, testing, and tracking platforms and solutions enabling manufacturers, brands, and trade organizations to convey proof of their product claims. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and COVID-19 diagnostic test kit to prevent virus spread within a community, school, or workplace under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. Further, it develops an invasive circulating tumor cell capture and identification technology that uses a patented functional assay to capture live invasive circulating tumor cell and associated lymphocytes. The company operates in the United States, Europe, Asia, and internationally. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
EPS | -0.550 |
Book Value | 0.310 |
PEG Ratio | 0.00 |
Gross Profit | 0.000 |
Profit Margin (%) | -80.13 |
Operating Margin (%) | -425.18 |
Return on Assets (ttm) | -56.0 |
Return on Equity (ttm) | -110.0 |
Thu, 28 Mar 2024
Applied DNA Sciences (NASDAQ:APDN) Earns Hold Rating from Analysts at StockNews.com - Defense World
Tue, 19 Mar 2024
Will Applied DNA Sciences Inc (APDN) Trail the Rest of the Stocks in the Healthcare Sector? - InvestorsObserver
Mon, 18 Mar 2024
Applied DNA Sciences Inc (APDN) Stock Decreases -16.98% This Week; Should You Buy? - InvestorsObserver
Thu, 14 Mar 2024
Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress - Yahoo Finance
Tue, 12 Mar 2024
StockNews.com Initiates Coverage on Applied DNA Sciences (NASDAQ:APDN) - Defense World
Wed, 21 Feb 2024
Is Applied DNA Sciences (APDN) Outperforming Other Industrial Products Stocks This Year? - Yahoo Finance
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |